tiprankstipranks
Company Announcements

Bio-Gene Technology to Present at NWR Virtual Healthcare Conference

Story Highlights
Bio-Gene Technology to Present at NWR Virtual Healthcare Conference

The latest update is out from Bio-Gene Technology Ltd. ( (AU:BGT) ).

Bio-Gene Technology Limited announced its participation in the NWR Virtual Healthcare Conference, where CEO Tim Grogan will present on the company’s innovative insecticide solutions. This presentation highlights Bio-Gene’s commitment to addressing pest control challenges and could enhance its visibility and positioning in the bio-insecticide industry, potentially impacting stakeholders by showcasing its environmentally friendly and effective products.

More about Bio-Gene Technology Ltd.

Bio-Gene Technology Limited is an Australian company focused on developing novel bio-insecticides to tackle global challenges related to insecticide resistance and toxicity. Their products, based on naturally occurring compounds, aim to control pests effectively while minimizing health and environmental impacts. The company’s solutions have applications in public health, crop protection, grain storage, and consumer use, meeting the demand for safe pest management.

YTD Price Performance: -30.23%

Average Trading Volume: 1,061,558

Technical Sentiment Consensus Rating: Buy

Current Market Cap: A$6.04M

See more insights into BGT stock on TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App